SUBSEQUENT EVENTS (Details - Narrative) - $ / shares |
Apr. 14, 2026 |
Jan. 19, 2026 |
|---|---|---|
| Placement Agent Agreement [Member] | Registered Direct Offering [Member] | Common Stock [Member] | Placement Agent Warrants [Member] | ||
| Subsequent Event [Line Items] | ||
| Number of shares of common stock for conversion upon warrants | 94,625 | |
| Exercise Price of Warrants | $ 16.5125 | |
| Subsequent Event [Member] | ||
| Subsequent Event [Line Items] | ||
| Subsequent Event, Description | On April 14, 2026, the Company entered into a Mutual Collaboration Agreement (the "Collaboration Agreement") with Foris DAX Markets, Inc., d/b/a Crypto.com, and its affiliates, including North American Derivatives Exchange, Inc. d/b/a Crypto.com | Derivatives North America ("CDNA") and Foris DAX FCM, LLC. Pursuant to the Collaboration Agreement, the Company will serve as a guaranteed introducing broker for the purpose of soliciting customers to trade event-based derivative contracts in CDNA's Predictions product class (the "Predictions Contracts") on the CDNA trading system. The Company is responsible for, among other things, developing, implementing, and maintaining a technology platform, available as a mobile application, through which end-user customers may access and trade Predictions Contracts. CDNA will be the exclusive provider of Predictions Contracts through the Company's technology in the United States for the first 24 months of the term of the Collaboration Agreement. The Collaboration Agreement has an initial term of two years, with automatic renewal for a 12-month period, unless terminated earlier in accordance with its provisions. Subsequent events have been evaluated through the date the original condensed financial statements were issued. In connection with the restatement described in Note 18, the Company also considered whether subsequent developments required additional disclosure. No additional disclosures were identified as necessary. |